7.3 Oncogene Amplification
Oncogene amplification drives cancer by increasing gene copies, leading to uncontrolled cell growth and tumor formation.
Oncogene Amplification is the genetic alteration in which the number of copies of an oncogene within a cell's genome is increased far beyond the normal two copies, resulting in proportionally elevated expression of the encoded protein and a correspondingly enhanced growth-promoting or survival signal, without requiring any change to the intrinsic structure or activity of the protein itself.
The Basic Mechanism
Copy Number Increase
Amplification produces multiple additional copies of a chromosomal region containing an oncogene, ranging from a few extra copies to, in extreme cases, hundreds of copies within a single cell, achieved through abnormal DNA replication processes that repeatedly duplicate the same genomic segment.
Dosage-Driven Overexpression
Because gene expression is generally proportional to gene copy number, amplification increases the quantity of oncogenic protein produced by the cell, achieving a functionally significant increase in signaling output purely through elevated dosage rather than through any qualitative change in the protein's behavior.
Structural Forms of Amplified DNA
Homogeneously Staining Regions
Amplified DNA can become integrated within a chromosome as an expanded, tandemly repeated segment, producing a chromosomal region that stains uniformly under certain cytogenetic techniques, referred to as a homogeneously staining region, reflecting the repetitive nature of the amplified sequence.
Double Minute Chromosomes
Alternatively, amplified sequences can exist as small, extrachromosomal, circular DNA fragments called double minute chromosomes, which lack centromeres and are unevenly distributed to daughter cells during division, allowing rapid, unequal amplification and further copy number increase within a growing cell population.
Mechanisms Generating Amplification
Replication-Associated Errors
Amplification frequently arises from errors during DNA replication, including breakage-fusion-bridge cycles, in which a broken chromosome fuses with a sister chromatid, is pulled apart unevenly during cell division, and breaks again, repeatedly duplicating the involved genomic segment across successive divisions.
Selection for Amplified Clones
Once an amplification event occurs, cells carrying the additional oncogene copies, and the resulting elevated signaling, may gain a proliferative or survival advantage over their neighbors, leading to selective expansion of the amplified clone within the developing tumor.
Commonly Amplified Oncogenes
Growth Factor Receptor and Transcription Factor Genes
Genes frequently subject to amplification in human cancers include those encoding growth factor receptors and key transcription factors, whose overexpression drives excessive proliferative signaling or transcriptional activation of growth-promoting gene programs.
Tumor-Type Specific Patterns
The specific oncogenes most commonly amplified, and the frequency of amplification, vary considerably among different tumor types, reflecting differences in the underlying signaling dependencies of each cancer's cell of origin.
Functional and Clinical Consequences
Enhanced Oncogenic Signaling
Amplification-driven overexpression can push signaling pathway activity well beyond the level achievable through normal regulatory mechanisms, contributing to sustained proliferation, resistance to apoptosis, and, in some cases, increased dependence of the tumor cell on the amplified pathway for its continued survival, a phenomenon termed oncogene addiction.
Diagnostic and Therapeutic Relevance
Detection of oncogene amplification in a tumor sample carries prognostic significance and can guide the selection of targeted therapies designed specifically to inhibit the overexpressed protein or its downstream signaling, making amplification status an important consideration in the molecular characterization of many cancers.